Reduced naïve CD8(+) T-cell priming efficacy in elderly adults

Area of Science:

• Immunology
• Gerontology
• Cellular Biology

Background:

• Aging impairs immune responses, increasing vulnerability to infections and cancers.
• CD8(+) T-cells are crucial for fighting pathogens and tumors.
• Reduced naive CD8(+) T-cells in aged individuals may hinder new immune responses, but human data is lacking.

Purpose of the Study:

• To investigate the efficacy of CD8(+) T-cell priming in elderly humans.
• To explore the quantitative and qualitative aspects of de novo T-cell responses in aging.

Main Methods:

• Development of an in vitro assay using accelerated dendritic cell coculture.
• Analysis of peripheral blood mononuclear cells from human volunteers of varying ages.
• Examination of CD8(+) T-cell priming against a model antigen.

Main Results:

• Elderly individuals exhibited significantly impaired de novo CD8(+) T-cell responses, both quantitatively and qualitatively.
• Reduced in vitro T-cell priming capacity correlated with diminished in vivo immune responsiveness.
• Deficiencies were attributed to intrinsic cellular defects and a smaller naive CD8(+) T-cell pool.

Conclusions:

• Human aging is characterized by cellular immune insufficiencies affecting CD8(+) T-cell function.
• Impaired T-cell priming in older adults contributes to reduced vaccine efficacy and increased disease risk.
• Findings highlight the need for strategies to bolster T-cell immunity in the elderly.